# US 6,725,866 B2 · Method of treating gastroesophageal reflux disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,725,866 B2
- Document ID: US6725866B2
- Status: Granted
- Kind: B2
- Application number: 10/165,518
- Filed: 2002-06-07
- Published: 2002-10-17
- Granted: 2004-04-27
- Earliest claimed: 1999-04-07
- Assignees: Medtronic Endonetics, Inc.
- Inventors: George M. Johnson; Ross Tsukashima; Matthew Thomas Yurek
- Web page: https://patentgrep.com/patent/US6725866B2

## CPC

- A61B 17/12036: {partial occlusion}
- A61B 17/12022: {Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20)}
- A61B 17/12099: {characterised by the location of the occluder}
- A61B 17/12131: {characterised by the type of occluding device}
- A61B 17/12136: {Balloons}
- A61B 17/12186: {liquid materials adapted to be injected}
- A61B 17/1219: {expandable in contact with liquids}
- A61F 2/0036: {implantable (A61F2/0018 takes precedence)}
- A61B 17/00491: {Surgical glue applicators}
- A61B 17/3478: {Endoscopic needles, e.g. for infusion (biopsy needles A61B10/0233; catheters with injection needles A61M25/0067)}
- A61B 2017/00269: {endoscopic mucosal resection EMR}
- A61B 2017/00827: {Treatment of gastro-esophageal reflux}
- A61B 2017/1205: {Introduction devices}
- A61B 2017/306: {holding by means of suction}
- A61F 2/20: Larynxes; Tracheae combined with larynxes or for use therewith
- A61F 2002/044: {Oesophagi or esophagi or gullets}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Disclosed is an esophageal bulking device for implantation below the mucosa in the vicinity of the lower esophageal sphincter. Preferably, the bulking device comprises an expandable hydrogel implant. Also disclosed are methods of treating gastroesophageal reflux disease, by implanting an expandable bulking device below the mucosa in the vicinity of the lower esophageal sphincter. The bulking device may be subsequently explanted from the vicinity of the lower esophageal sphincter.

## Claims

### Claim 1

A method of treating gastroesophageal reflux disease, comprising the steps of:
providing a catheter having an opening thereon;
positioning the opening at a treatment site in the esophagus;
drawing tissue at the treatment site into the opening; and
deploying an expandable hydrogel bulking device into the tissue at the treatment site, in the vicinity of the lower esophageal sphincter.

### Claim 2 (depends on 1)

The method of claim 1, wherein the deploying step comprises inserting two or more bulking devices.

### Claim 3 (depends on 1)

The method of claim 1, wherein the bulking device comprises an expandable hydrogel rod.

### Claim 4 (depends on 1)

The method of claim 1, wherein the bulking device comprises an expansion ratio of at least about 100%.

### Claim 5 (depends on 3)

The method of claim 3, wherein the hydrogel rod has an expanded length within the range of from about 0.5 cm to about 5 cm.

### Claim 6 (depends on 3)

The method of claim 3, wherein the hydrogel rod has an expanded width within the range of from about 0.2 cm to about 2 cm.

### Claim 7 (depends on 3)

The method of claim 3, wherein the hydrogel rod has an unexpanded diameter of about 2 mm.

### Claim 8 (depends on 1)

The method of claim 1, wherein the deploying step comprises inserting the bulking device in the submucosa.

### Claim 9 (depends on 1)

The method of claim 1, further comprising the step of injecting a volume of fluid below the mucosa to create a pocket prior to the inserting step.

### Claim 10 (depends on 1)

The method of claim 1, wherein the bulking device has a length to thickness ratio of no more than about 15:1.

### Claim 11 (depends on 1)

The method of claim 1, further comprising the step of explanting the esophageal bulking device from the vicinity of the lower esophageal sphincter.

### Claim 12

A method of treating gastroesophageal reflux disease, comprising the steps of:
providing an implantation device having a tissue stabilization surface thereon;
positioning the device in the esophagus and drawing tissue towards the tissue stabilization surface; and
inserting an expandable hydrogel esophageal bulking device into the tissue in the vicinity of the lower esophageal sphincter.

### Claim 13 (depends on 12)

A method as in claim 12, wherein the drawing tissue step is accomplished using suction.

### Claim 14 (depends on 13)

A method as in claim 13, wherein the esophageal bulking device comprises an expandable hydrogel rod.

### Claim 15 (depends on 14)

A method as in claim 14, wherein the hydrogel comprises an acrilonitrile acrylic copolymer.

### Claim 16 (depends on 14)

A method as in claim 14, wherein the bulking device comprises an expansion ratio of at least about 100%.

### Claim 17 (depends on 14)

A method as in claim 14, wherein the hydrogel rod has an expanded length within the range of from about 0.5 cm to about 5 cm.

### Claim 18 (depends on 14)

A method as in claim 14, wherein the hydrogel rod has an expanded width within the range of from about 0.2 cm to about 2 cm.

### Claim 19 (depends on 14)

A method as in claim 14, wherein the hydrogel rod has an unexpanded diameter of about 2 mm.

### Claim 20

A method of reestablishing lower esophageal sphincter function, comprising the steps of:
trans-esophageally introducing a deployment device to a treatment site in the vicinity of the lower esophageal sphincter;
drawing tissue into a cavity on the deployment device;
providing an access pathway through the tissue; and
introducing an expandable bulking device into the wall of the esophagus in the vicinity of the cavity, so that the bulking device cooperates with the lower esophageal sphincter to reestablish sphincter function.

### Claim 21 (depends on 20)

The method of claim 20, wherein the bulking device increases the closing pressure of the sphincter along an axial length of at least about 1.5 cm.

### Claim 22 (depends on 20)

The method of claim 20, wherein the closing pressure following implantation of the bulking device is at least about 10 mm Hg.

### Claim 23 (depends on 22)

The method of claim 22, wherein the closing pressure in the lower esophageal sphincter following implantation is within the range of from about 10 mm Hg to about 30 mm Hg.

### Claim 24 (depends on 20)

The method of claim 20, wherein the closing pressure following implantation of the bulking device is at least about 18 mm Hg along a length of at least about 2 cm.

### Claim 25 (depends on 20)

The method of claim 20, wherein the inserting step comprises inserting at least two bulking devices.

### Claim 26 (depends on 20)

The method of claim 20, wherein the bulking device comprises an expansion ratio of at least about 100%.

### Claim 27 (depends on 20)

The method of claim 20, wherein the bulking device comprises a hydrogel rod.

### Claim 28 (depends on 27)

The method of claim 27, wherein the hydrogel rod has an expanded cross section within the range of from about 0.2 cm to about 2 cm.

### Claim 29 (depends on 27)

The method of claim 27, wherein the hydrogel rod has an unexpanded cross section of about 2 mm.

### Claim 30 (depends on 20)

The method of claim 20, wherein the inserting step comprises inserting the bulking device in the submucosa.

### Claim 31 (depends on 20)

The method of claim 20, further comprising the step of injecting a volume of fluid below the mucosa to create a pocket prior to the inserting step.

### Claim 32 (depends on 20)

The method of claim 20, wherein the bulking device has a length to thickness ratio of no more than about 15:1.

### Claim 33 (depends on 20)

The method of claim 20, further comprising the step of explanting the esophageal bulking device from the vicinity of the lower esophageal sphincter.

### Claim 34

A method of treating gastroesophageal reflux disease, comprising the steps of:
identifying a patient having gastroesophageal reflux disease;
stabilizing mucosa at a treatment site in the vicinity of the patient's lower esophageal sphincter by drawing mucosa into contact with a tissue stabilizing surface;
introducing a tubular body through the mucosa; and
deploying at least one expandable bulking device from the tubular body beneath the stabilized mucosa.

### Claim 35 (depends on 34)

A method of treating gastroesophageal reflux disease as in claim 34, wherein the deploying step comprises implanting at least one expandable rod.

### Claim 36 (depends on 35)

A method of treating gastroesophageal reflux disease as in claim 35, wherein the rod comprises a hydrogel.

### Claim 37 (depends on 34)

The method of claim 34, wherein the bulking device comprises an expansion ratio of at least about 100%.

### Claim 38 (depends on 36)

The method of claim 36, wherein the hydrogel rod has an expanded length within the range of from about 0.5 cm to about 5 cm.

### Claim 39 (depends on 36)

The method of claim 36, wherein the hydrogel rod has an expanded width within the range of from about 0.2 cm to about 2 cm.

### Claim 40 (depends on 36)

The method of claim 36, wherein the hydrogel rod has an unexpanded diameter of about 2 mm.

### Claim 41 (depends on 34)

The method of claim 34, wherein the implanting step comprises implanting the bulking device in the submucosa.

### Claim 42 (depends on 34)

The method of claim 34, wherein the bulking device has a length to thickness ratio of no more than about 15:1.
